A Standardized Approach to Orthotopic (Life-supporting) Porcine Cardiac Xenotransplantation in a Nonhuman Primate Model

Cardiac xenotransplantation from swine has been proposed to “bridge the gap” in supply for heart failure patients requiring transplantation. Recent preclinical success using genetically modified pig donors in baboon recipients has demonstrated survival greater than 6 mo, with a modern understanding of xenotransplantation immunobiology and continued experience with large animal models of cardiac xenotransplantation. As a direct result of this expertise, the Food and Drug Administration approved the first in-human transplantation of a genetically engineered cardiac xenograft through an expanded access application for a single patient. This clinical case demonstrated the feasibility of xenotransplantation. Although this human study demonstrated proof-of-principle application of cardiac xenotransplantation, further regulatory oversight by the Food and Drug Administration may be required with preclinical trials in large animal models of xenotransplantation with long-term survival before approval of a more formalized clinical trial. Here we detail our surgical approach to pig-to-primate large animal models of orthotopic cardiac xenotransplantation, and the postoperative care of the primate recipient, both in the immediate postoperative period and in the months thereafter. We also detail xenograft surveillance methods and common issues that arise in the postoperative period specific to this model and ways to overcome them. These studies require multidisciplinary teams and expertise in orthotopic transplantation (cardiac surgery, anesthesia, and cardiopulmonary bypass), immunology, genetic engineering, and experience in handling large animal donors and recipients, which are described here. This article serves to reduce the barriers to entry into a field with ever-growing enthusiasm, but demands expertise knowledge and experience to be successful.

[1]  B. Griffith,et al.  The immunobiology and clinical use of genetically engineered porcine hearts for cardiac xenotransplantation , 2022, Nature Cardiovascular Research.

[2]  B. Griffith,et al.  Anatomical Differences Between Human and Pig Hearts and Their Relevance for Cardiac Xenotransplantation Surgical Technique , 2022, JACC. Case reports.

[3]  B. Griffith,et al.  Genetically Modified Porcine-to-Human Cardiac Xenotransplantation. , 2022, The New England journal of medicine.

[4]  B. Griffith,et al.  Progressive genetic modifications of porcine cardiac xenografts extend survival to 9 months , 2022, Xenotransplantation.

[5]  D. Ayares,et al.  Cardiac Xenotransplantation: Progress in Preclinical Models and Prospects for Clinical Translation , 2022, Transplant International.

[6]  L. Buhler,et al.  International Human Xenotransplantation Inventory: A 10-year Follow-up , 2022, Transplantation.

[7]  B. Griffith,et al.  The growth of xenotransplanted hearts can be reduced with growth hormone receptor knockout pig donors. , 2021, The Journal of thoracic and cardiovascular surgery.

[8]  B. Griffith,et al.  Blood Cardioplegia Induction, Perfusion Storage and Graft Dysfunction in Cardiac Xenotransplantation , 2021, Frontiers in Immunology.

[9]  E. Wolf,et al.  Pathways to Clinical Cardiac Xenotransplantation. , 2020, Transplantation.

[10]  R. Pierson,et al.  Progress Toward Cardiac Xenotransplantation , 2020, Circulation.

[11]  E. Wolf,et al.  Cold non‐ischemic heart preservation with continuous perfusion prevents early graft failure in orthotopic pig‐to‐baboon xenotransplantation , 2020, Xenotransplantation.

[12]  Ulrich Dirnagl,et al.  The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research* , 2020, BMC Veterinary Research.

[13]  D. Ayares,et al.  Heterotopic Porcine Cardiac Xenotransplantation in the Intra-Abdominal Position in a Non-Human Primate Model , 2020, Scientific Reports.

[14]  J. Platt,et al.  Clinical xenotransplantation of the heart: At the watershed. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  B. Griffith,et al.  Early experience with preclinical peri-operative cardiac xenograft dysfunction in a single program. , 2020, The Annals of thoracic surgery.

[16]  J. Copeland,et al.  Donor heart and lung procurement: A consensus statement. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  M. Mohiuddin,et al.  Regulatory barriers to xenotransplantation. , 2019, Current opinion in organ transplantation.

[18]  E. Wolf,et al.  Third WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials, Changsha, Hunan, China December 12–14, 2018 , 2019, Xenotransplantation.

[19]  E. Wolf,et al.  Consistent success in life-supporting porcine cardiac xenotransplantation , 2018, Nature.

[20]  Marvin L. Thomas,et al.  Circulating cell-free DNA as a biomarker of tissue injury: Assessment in a cardiac xenotransplantation model. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  R. Pierson Brief Summary Report From the 14th Biennial Meeting of the International Xenotransplantation Association , 2018, Transplantation.

[22]  R. Pierson,et al.  Regulation of Clinical Xenotransplantation-Time for a Reappraisal. , 2017, Transplantation.

[23]  R. Pierson,et al.  Selection of Patients for Initial Clinical Trials of Solid Organ Xenotransplantation. , 2017, Transplantation.

[24]  R. F. Hoyt,et al.  Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft , 2016, Nature Communications.

[25]  R. Pierson,et al.  Development of a consensus protocol to quantify primate anti‐non‐Gal xenoreactive antibodies using pig aortic endothelial cells , 2014, Xenotransplantation.

[26]  A. Angelini,et al.  The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  Roxy Senior,et al.  Contrast echocardiography: evidence for clinical use. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  Tien-Shuh Yang Size concerns regarding pig hearts for xenotransplantation , 2006, Xenotransplantation.

[29]  Linda J Stang,et al.  Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy. , 2005, The Journal of antimicrobial chemotherapy.

[30]  R. Steeds,et al.  The echocardiographic assessment of donor heart function prior to cardiac transplantation. , 2005, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[31]  J. Morgan,et al.  Orthotopic Cardiac Transplantation: Comparison of Outcome Using Biatrial, Bicaval, and Total Techniques , 2005, Journal of cardiac surgery.

[32]  K. Farrington,et al.  Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. , 2003, Journal of Antimicrobial Chemotherapy.

[33]  R. Pierson,et al.  Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  C. Blanche,et al.  Surgical techniques for cardiac transplantation. , 1996, Seminars in thoracic and cardiovascular surgery.

[35]  D. Renlund,et al.  Echocardiographic evaluation of potential cardiac transplant donors. , 1988, The Journal of thoracic and cardiovascular surgery.

[36]  J. Prothero Heart weight as a function of body weight in mammals. , 1979, Growth.

[37]  E. Stinson,et al.  Transplantation of the heart. , 1963, Surgery annual.

[38]  M. Kokkinaki,et al.  Gene-edited Pigs for Xenotransplantation , 2020 .

[39]  D. Cooper,et al.  Clinical Xenotransplantation: Pathways and Progress in the Transplantation of Organs and Tissues Between Species , 2020 .

[40]  Torsten B. Moeller,et al.  Books Received Pocket Atlas of Sectional Anatomy — Volume I : Head and Neck : 4th Edition Copyright © North American Neuro- O phthalmology Society . Unauthorized reproduction of this article is prohibited . , 2018 .

[41]  N. Mueller,et al.  Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience , 2005, Nature Medicine.